• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global protein therapeutics market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global protein therapeutics market 2017 – 2021 ($ billion)
o 4.2 Product Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ billion)
o 4.3 Application Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Application Segment 2017 – 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 mAbs – Market size and forecast 2022-2027
o Exhibit 34: Chart on mAbs – Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on mAbs – Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on mAbs – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on mAbs – Year-over-year growth 2022-2027 (%)
o 6.4 Human insulin – Market size and forecast 2022-2027
o Exhibit 38: Chart on Human insulin – Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Human insulin – Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Human insulin – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Human insulin – Year-over-year growth 2022-2027 (%)
o 6.5 Erythropoeitin – Market size and forecast 2022-2027
o Exhibit 42: Chart on Erythropoeitin – Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on Erythropoeitin – Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on Erythropoeitin – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Erythropoeitin – Year-over-year growth 2022-2027 (%)
o 6.6 Clotting factors – Market size and forecast 2022-2027
o Exhibit 46: Chart on Clotting factors – Market size and forecast 2022-2027 ($ billion)
o Exhibit 47: Data Table on Clotting factors – Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Chart on Clotting factors – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Clotting factors – Year-over-year growth 2022-2027 (%)
o 6.7 Others – Market size and forecast 2022-2027
o Exhibit 50: Chart on Others – Market size and forecast 2022-2027 ($ billion)
o Exhibit 51: Data Table on Others – Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Product
o Exhibit 54: Market opportunity by Product ($ billion)
o Exhibit 55: Data Table on Market opportunity by Product ($ billion)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 56: Chart on Application – Market share 2022-2027 (%)
o Exhibit 57: Data Table on Application – Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 58: Chart on Comparison by Application
o Exhibit 59: Data Table on Comparison by Application
o 7.3 Metabolic disorders – Market size and forecast 2022-2027
o Exhibit 60: Chart on Metabolic disorders – Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Data Table on Metabolic disorders – Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Chart on Metabolic disorders – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Metabolic disorders – Year-over-year growth 2022-2027 (%)
o 7.4 Immunologic disorders – Market size and forecast 2022-2027
o Exhibit 64: Chart on Immunologic disorders – Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Data Table on Immunologic disorders – Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Chart on Immunologic disorders – Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Immunologic disorders – Year-over-year growth 2022-2027 (%)
o 7.5 Hematological disorders – Market size and forecast 2022-2027
o Exhibit 68: Chart on Hematological disorders – Market size and forecast 2022-2027 ($ billion)
o Exhibit 69: Data Table on Hematological disorders – Market size and forecast 2022-2027 ($ billion)
o Exhibit 70: Chart on Hematological disorders – Year-over-year growth 2022-2027 (%)
o Exhibit 71: Data Table on Hematological disorders – Year-over-year growth 2022-2027 (%)
o 7.6 Cancer – Market size and forecast 2022-2027
o Exhibit 72: Chart on Cancer – Market size and forecast 2022-2027 ($ billion)
o Exhibit 73: Data Table on Cancer – Market size and forecast 2022-2027 ($ billion)
o Exhibit 74: Chart on Cancer – Year-over-year growth 2022-2027 (%)
o Exhibit 75: Data Table on Cancer – Year-over-year growth 2022-2027 (%)
o 7.7 Genetic disorders – Market size and forecast 2022-2027
o Exhibit 76: Chart on Genetic disorders – Market size and forecast 2022-2027 ($ billion)
o Exhibit 77: Data Table on Genetic disorders – Market size and forecast 2022-2027 ($ billion)
o Exhibit 78: Chart on Genetic disorders – Year-over-year growth 2022-2027 (%)
o Exhibit 79: Data Table on Genetic disorders – Year-over-year growth 2022-2027 (%)
o 7.8 Market opportunity by Application
o Exhibit 80: Market opportunity by Application ($ billion)
o Exhibit 81: Data Table on Market opportunity by Application ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 83: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 84: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 85: Chart on Geographic comparison
o Exhibit 86: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 87: Chart on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 91: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 95: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 99: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 103: Chart on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 104: Data Table on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 105: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Canada – Market size and forecast 2022-2027
o Exhibit 107: Chart on Canada – Market size and forecast 2022-2027 ($ billion)
o Exhibit 108: Data Table on Canada – Market size and forecast 2022-2027 ($ billion)
o Exhibit 109: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 111: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 112: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 113: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 114: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 UK – Market size and forecast 2022-2027
o Exhibit 115: Chart on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 116: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 117: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 118: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.11 China – Market size and forecast 2022-2027
o Exhibit 119: Chart on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 120: Data Table on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 121: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 122: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 123: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 125: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 127: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 128: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 129: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 130: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 131: AbbVie Inc. – Overview
o Exhibit 132: AbbVie Inc. – Product / Service
o Exhibit 133: AbbVie Inc. – Key news
o Exhibit 134: AbbVie Inc. – Key offerings
o 12.4 Amgen Inc.
o Exhibit 135: Amgen Inc. – Overview
o Exhibit 136: Amgen Inc. – Product / Service
o Exhibit 137: Amgen Inc. – Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 138: AstraZeneca Plc – Overview
o Exhibit 139: AstraZeneca Plc – Product / Service
o Exhibit 140: AstraZeneca Plc – Key news
o Exhibit 141: AstraZeneca Plc – Key offerings
o 12.6 Biogen Inc.
o Exhibit 142: Biogen Inc. – Overview
o Exhibit 143: Biogen Inc. – Product / Service
o Exhibit 144: Biogen Inc. – Key offerings
o 12.7 Bristol Myers Squibb Co.
o Exhibit 145: Bristol Myers Squibb Co. – Overview
o Exhibit 146: Bristol Myers Squibb Co. – Product / Service
o Exhibit 147: Bristol Myers Squibb Co. – Key news
o Exhibit 148: Bristol Myers Squibb Co. – Key offerings
o 12.8 Creative Biolabs
o Exhibit 149: Creative Biolabs – Overview
o Exhibit 150: Creative Biolabs – Product / Service
o Exhibit 151: Creative Biolabs – Key offerings
o 12.9 Eli Lilly and Co.
o Exhibit 152: Eli Lilly and Co. – Overview
o Exhibit 153: Eli Lilly and Co. – Product / Service
o Exhibit 154: Eli Lilly and Co. – Key offerings
o 12.10 F. Hoffmann La Roche Ltd.
o Exhibit 155: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 156: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 157: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 158: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 159: F. Hoffmann La Roche Ltd. – Segment focus
o 12.11 Ipsen Pharma
o Exhibit 160: Ipsen Pharma – Overview
o Exhibit 161: Ipsen Pharma – Business segments
o Exhibit 162: Ipsen Pharma – Key offerings
o Exhibit 163: Ipsen Pharma – Segment focus
o 12.12 Johnson and Johnson Services Inc.
o Exhibit 164: Johnson and Johnson Services Inc. – Overview
o Exhibit 165: Johnson and Johnson Services Inc. – Business segments
o Exhibit 166: Johnson and Johnson Services Inc. – Key news
o Exhibit 167: Johnson and Johnson Services Inc. – Key offerings
o Exhibit 168: Johnson and Johnson Services Inc. – Segment focus
o 12.13 LGM Pharma LLC
o Exhibit 169: LGM Pharma LLC – Overview
o Exhibit 170: LGM Pharma LLC – Product / Service
o Exhibit 171: LGM Pharma LLC – Key offerings
o 12.14 Novartis AG
o Exhibit 172: Novartis AG – Overview
o Exhibit 173: Novartis AG – Business segments
o Exhibit 174: Novartis AG – Key offerings
o Exhibit 175: Novartis AG – Segment focus
o 12.15 Novo Nordisk AS
o Exhibit 176: Novo Nordisk AS – Overview
o Exhibit 177: Novo Nordisk AS – Business segments
o Exhibit 178: Novo Nordisk AS – Key offerings
o Exhibit 179: Novo Nordisk AS – Segment focus
o 12.16 Pfizer Inc.
o Exhibit 180: Pfizer Inc. – Overview
o Exhibit 181: Pfizer Inc. – Product / Service
o Exhibit 182: Pfizer Inc. – Key news
o Exhibit 183: Pfizer Inc. – Key offerings
o 12.17 Sanofi SA
o Exhibit 184: Sanofi SA – Overview
o Exhibit 185: Sanofi SA – Business segments
o Exhibit 186: Sanofi SA – Key news
o Exhibit 187: Sanofi SA – Key offerings
o Exhibit 188: Sanofi SA – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 189: Inclusions checklist
o Exhibit 190: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 191: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 192: Research methodology
o Exhibit 193: Validation techniques employed for market sizing
o Exhibit 194: Information sources
o 13.5 List of abbreviations
o Exhibit 195: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Application
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global protein therapeutics market 2017 – 2021 ($ billion)
Exhibits19: Historic Market Size – Product Segment 2017 – 2021 ($ billion)
Exhibits20: Historic Market Size – Application Segment 2017 – 2021 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on mAbs – Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on mAbs – Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on mAbs – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on mAbs – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Human insulin – Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Human insulin – Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Human insulin – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Human insulin – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Erythropoeitin – Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Erythropoeitin – Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Erythropoeitin – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Erythropoeitin – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Clotting factors – Market size and forecast 2022-2027 ($ billion)
Exhibits47: Data Table on Clotting factors – Market size and forecast 2022-2027 ($ billion)
Exhibits48: Chart on Clotting factors – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Clotting factors – Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others – Market size and forecast 2022-2027 ($ billion)
Exhibits51: Data Table on Others – Market size and forecast 2022-2027 ($ billion)
Exhibits52: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Product ($ billion)
Exhibits55: Data Table on Market opportunity by Product ($ billion)
Exhibits56: Chart on Application – Market share 2022-2027 (%)
Exhibits57: Data Table on Application – Market share 2022-2027 (%)
Exhibits58: Chart on Comparison by Application
Exhibits59: Data Table on Comparison by Application
Exhibits60: Chart on Metabolic disorders – Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Metabolic disorders – Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Metabolic disorders – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Metabolic disorders – Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Immunologic disorders – Market size and forecast 2022-2027 ($ billion)
Exhibits65: Data Table on Immunologic disorders – Market size and forecast 2022-2027 ($ billion)
Exhibits66: Chart on Immunologic disorders – Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Immunologic disorders – Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Hematological disorders – Market size and forecast 2022-2027 ($ billion)
Exhibits69: Data Table on Hematological disorders – Market size and forecast 2022-2027 ($ billion)
Exhibits70: Chart on Hematological disorders – Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Hematological disorders – Year-over-year growth 2022-2027 (%)
Exhibits72: Chart on Cancer – Market size and forecast 2022-2027 ($ billion)
Exhibits73: Data Table on Cancer – Market size and forecast 2022-2027 ($ billion)
Exhibits74: Chart on Cancer – Year-over-year growth 2022-2027 (%)
Exhibits75: Data Table on Cancer – Year-over-year growth 2022-2027 (%)
Exhibits76: Chart on Genetic disorders – Market size and forecast 2022-2027 ($ billion)
Exhibits77: Data Table on Genetic disorders – Market size and forecast 2022-2027 ($ billion)
Exhibits78: Chart on Genetic disorders – Year-over-year growth 2022-2027 (%)
Exhibits79: Data Table on Genetic disorders – Year-over-year growth 2022-2027 (%)
Exhibits80: Market opportunity by Application ($ billion)
Exhibits81: Data Table on Market opportunity by Application ($ billion)
Exhibits82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits83: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits84: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits85: Chart on Geographic comparison
Exhibits86: Data Table on Geographic comparison
Exhibits87: Chart on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on US – Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on US – Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Canada – Market size and forecast 2022-2027 ($ billion)
Exhibits108: Data Table on Canada – Market size and forecast 2022-2027 ($ billion)
Exhibits109: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits112: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits113: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits115: Chart on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits116: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits117: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits118: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits119: Chart on China – Market size and forecast 2022-2027 ($ billion)
Exhibits120: Data Table on China – Market size and forecast 2022-2027 ($ billion)
Exhibits121: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits122: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits123: Market opportunity By Geographical Landscape ($ billion)
Exhibits124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits125: Impact of drivers and challenges in 2022 and 2027
Exhibits126: Overview on Criticality of inputs and Factors of differentiation
Exhibits127: Overview on factors of disruption
Exhibits128: Impact of key risks on business
Exhibits129: Vendors covered
Exhibits130: Matrix on vendor position and classification
Exhibits131: AbbVie Inc. – Overview
Exhibits132: AbbVie Inc. – Product / Service
Exhibits133: AbbVie Inc. – Key news
Exhibits134: AbbVie Inc. – Key offerings
Exhibits135: Amgen Inc. – Overview
Exhibits136: Amgen Inc. – Product / Service
Exhibits137: Amgen Inc. – Key offerings
Exhibits138: AstraZeneca Plc – Overview
Exhibits139: AstraZeneca Plc – Product / Service
Exhibits140: AstraZeneca Plc – Key news
Exhibits141: AstraZeneca Plc – Key offerings
Exhibits142: Biogen Inc. – Overview
Exhibits143: Biogen Inc. – Product / Service
Exhibits144: Biogen Inc. – Key offerings
Exhibits145: Bristol Myers Squibb Co. – Overview
Exhibits146: Bristol Myers Squibb Co. – Product / Service
Exhibits147: Bristol Myers Squibb Co. – Key news
Exhibits148: Bristol Myers Squibb Co. – Key offerings
Exhibits149: Creative Biolabs – Overview
Exhibits150: Creative Biolabs – Product / Service
Exhibits151: Creative Biolabs – Key offerings
Exhibits152: Eli Lilly and Co. – Overview
Exhibits153: Eli Lilly and Co. – Product / Service
Exhibits154: Eli Lilly and Co. – Key offerings
Exhibits155: F. Hoffmann La Roche Ltd. – Overview
Exhibits156: F. Hoffmann La Roche Ltd. – Business segments
Exhibits157: F. Hoffmann La Roche Ltd. – Key news
Exhibits158: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits159: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits160: Ipsen Pharma – Overview
Exhibits161: Ipsen Pharma – Business segments
Exhibits162: Ipsen Pharma – Key offerings
Exhibits163: Ipsen Pharma – Segment focus
Exhibits164: Johnson and Johnson Services Inc. – Overview
Exhibits165: Johnson and Johnson Services Inc. – Business segments
Exhibits166: Johnson and Johnson Services Inc. – Key news
Exhibits167: Johnson and Johnson Services Inc. – Key offerings
Exhibits168: Johnson and Johnson Services Inc. – Segment focus
Exhibits169: LGM Pharma LLC – Overview
Exhibits170: LGM Pharma LLC – Product / Service
Exhibits171: LGM Pharma LLC – Key offerings
Exhibits172: Novartis AG – Overview
Exhibits173: Novartis AG – Business segments
Exhibits174: Novartis AG – Key offerings
Exhibits175: Novartis AG – Segment focus
Exhibits176: Novo Nordisk AS – Overview
Exhibits177: Novo Nordisk AS – Business segments
Exhibits178: Novo Nordisk AS – Key offerings
Exhibits179: Novo Nordisk AS – Segment focus
Exhibits180: Pfizer Inc. – Overview
Exhibits181: Pfizer Inc. – Product / Service
Exhibits182: Pfizer Inc. – Key news
Exhibits183: Pfizer Inc. – Key offerings
Exhibits184: Sanofi SA – Overview
Exhibits185: Sanofi SA – Business segments
Exhibits186: Sanofi SA – Key news
Exhibits187: Sanofi SA – Key offerings
Exhibits188: Sanofi SA – Segment focus
Exhibits189: Inclusions checklist
Exhibits190: Exclusions checklist
Exhibits191: Currency conversion rates for US$
Exhibits192: Research methodology
Exhibits193: Validation techniques employed for market sizing
Exhibits194: Information sources
Exhibits195: List of abbreviations